This finding is very interesting because elevated levels of Ccl3 have been documented in the serum and liver of patients with NASH and moreover the deletion of this gene protects mice from diet-induced steatohepatitis, hepatic fibrosis, and insulin resistance (Xu et al., 2021). This evidence concerns the gene CCL3 and Hepatic fibrosis.